AHRQ offers strategies to prevent adverse drug events

AHRQ offers strategies to prevent adverse drug events
Strategies to prevent adverse drug events have been recommended and published in a report by the Agency for Healthcare Research and Quality.

(HealthDay)—Strategies to prevent adverse drug events (ADEs) have been recommended and published in a report by the Agency for Healthcare Research and Quality (AHRQ).

Noting that ADEs account for nearly 700,000 emergency department visits and 100,000 hospitalizations each year, the AHRQ discusses risk factors for ADEs and ways to prevent them.

According to the report, risk factors for ADEs include polypharmacy and limited and numeracy. Elderly and are at elevated risk of ADEs. ADEs can occur as a result of errors in ordering, transcribing, dispensing, or administration of medications, with most ADEs caused by commonly used medications. To prevent ADEs, conservative prescribing principles should be adhered to, and computerized provider order entry and clinical decision support systems should be employed. In addition, medication reconciliation should be implemented at times of transition in care. To eliminate handwriting errors, computerized provider order entry should be used. should oversee the process of medication dispensation. Adherence to the "five rights" of is recommended (right medication, in the right dose, at the right time, by the right route, to the right patient). In addition, barcode medication administration, minimizing , use of smart infusion pumps, and patient education can all help prevent errors at the time of administration.

"Preventing ADEs is a major priority for accrediting and regulatory agencies," the authors write. "The Partnership for Patients has set a goal of reducing preventable ADEs in hospitalized patients by 50 percent by 2013, estimating that more than 800,000 ADEs could be prevented if this goal is met."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Thousands of patients prescribed high-risk drugs

Jun 22, 2011

Thousands of patients in Scotland who are particularly vulnerable to adverse drug events (ADEs) were prescribed high-risk medications by their GPs which could potentially cause them harm, according to research published in ...

Med errors common among pediatric cancer outpatients

Apr 29, 2013

(HealthDay)—Among pediatric cancer patients who receive medications at home, errors are common, with a rate of 3.6 errors with injury per 100 patients, according to a study published online April 29 in ...

Recommended for you

Supercomputers link proteins to drug side effects

17 hours ago

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments